CCCC
Price
$3.92
Change
-$0.14 (-3.45%)
Updated
Jul 13 closing price
Capitalization
433.42M
29 days until earnings call
Intraday BUY SELL Signals
REPL
Price
$9.94
Change
-$1.05 (-9.55%)
Updated
Jul 13 closing price
Capitalization
834M
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs REPL

CCCC vs REPL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CCCC vs. REPL commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Buy and REPL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (CCCC: $3.92 vs. REPL: $9.94)
Brand notoriety: CCCC and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 63% vs. REPL: 30%
Market capitalization -- CCCC: $433.42M vs. REPL: $834M
CCCC [@Biotechnology] is valued at $433.42M. REPL’s [@Biotechnology] market capitalization is $834M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileREPL’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • REPL’s FA Score: 0 green, 5 red.
According to our system of comparison, both CCCC and REPL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while REPL’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 4 bearish.
  • REPL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than REPL.

Price Growth

CCCC (@Biotechnology) experienced а -5.31% price change this week, while REPL (@Biotechnology) price change was -13.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 12, 2026.

REPL is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REPL($834M) has a higher market cap than CCCC($433M). CCCC YTD gains are higher at: 105.236 vs. REPL (2.212). CCCC has higher annual earnings (EBITDA): -101.2M vs. REPL (-303.89M). REPL has more cash in the bank: 269M vs. CCCC (236M). CCCC has less debt than REPL: CCCC (58.4M) vs REPL (76.3M). CCCC has higher revenues than REPL: CCCC (34.9M) vs REPL (0).
CCCCREPLCCCC / REPL
Capitalization433M834M52%
EBITDA-101.2M-303.89M33%
Gain YTD105.2362.2124,758%
P/E RatioN/AN/A-
Revenue34.9M0-
Total Cash236M269M88%
Total Debt58.4M76.3M77%
FUNDAMENTALS RATINGS
REPL: Fundamental Ratings
REPL
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCREPL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
REPL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDSRX25.760.04
+0.16%
Janus Henderson Small Cap Value R
FIKMX12.40N/A
N/A
Fidelity Advisor Real Estate Income Z
WCMOX14.77N/A
N/A
WCM Focused International Opps Ins
FEFAX30.74-0.18
-0.58%
First Eagle Rising Dividend Fund A
RNWHX103.56-2.49
-2.35%
American Funds New World R-5E

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-3.45%
AXON - CCCC
40%
Loosely correlated
-3.32%
CELC - CCCC
38%
Loosely correlated
-3.52%
REPL - CCCC
35%
Loosely correlated
-9.60%
WVE - CCCC
35%
Loosely correlated
-4.80%
ARRY - CCCC
35%
Loosely correlated
-3.92%
More

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-9.60%
IMNN - REPL
57%
Loosely correlated
-2.97%
SNDX - REPL
49%
Loosely correlated
-3.05%
KYMR - REPL
45%
Loosely correlated
-7.50%
NRIX - REPL
43%
Loosely correlated
-1.52%
ZYME - REPL
42%
Loosely correlated
-3.63%
More